References
Arcieri G, Griffith E, Gruenwaldt G, Heyd A, O'Brien B, Becker N, August R (1987) Ciprofloxacin: an up-date on clinical experience. Am J Med 82 [Suppl 4A]: 381–386
Winrow AP, Supramaniam G (1990) Benign intracranial hypertension after ciprofloxacin administration. Arch Dis Child 65: 1165–1166
Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58: 259–263
LeBel M (1988) Ciprofloxacin: chemistry, mechanism of action, resistance, anti-microbial spectrum, pharmacokinetics, clinical trial and adverse reactions. Pharmacotherapy 8: 3–33
Chyshky V, Kapila K, Hullmann R, Arcieri G, Schacht P, Echols R (1991) Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate uses. Emphasis on joint evaluation. Infection 19: 289–296
Schwartz MT, Calvert JF (1990) Potential neurologic toxicity related to ciprofloxacin. DICP Ann pharmacother 24: 138–140
Ball P (1986) Ciprofloxacin: an overview of adverse experiences. J Antimicrob Chemother 18 [Suppl D]: 187–193
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rfidah, E.I., Findlay, C.A. & Beattie, T.J. Reversible encephalopathy after intravenous ciprofloxacin therapy. Pediatr Nephrol 9, 250–251 (1995). https://doi.org/10.1007/BF00860763
Issue Date:
DOI: https://doi.org/10.1007/BF00860763